FDA 483 OBSERVATION · #26 OF 1,923 MOST-CITED
Sanitary facilities and controls
FDA cited this observation 784 times across 738 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
The plant’s sanitary facilities and controls were inadequate — water supply, plumbing, sewage disposal, toilet and hand-washing facilities, or rubbish disposal did not meet requirements that keep food from being contaminated.
Why FDA writes it — Basic sanitary infrastructure — safe water, adequate plumbing, hand-washing, sewage and waste control — is the foundation on which all other food hygiene rests. Deficiencies here create contamination routes that no downstream control can reliably compensate for, so FDA treats them as fundamental.
- Provide a water supply sufficient for operations and derived from an adequate source; water contacting food or surfaces must be safe and of adequate sanitary quality.
- Ensure plumbing is adequately sized and designed to carry sufficient water and convey sewage and liquid waste away, preventing contamination and backflow.
- Provide adequate, accessible hand-washing and toilet facilities, and keep them sanitary and in good repair.
- Dispose of rubbish and offal to minimise odor, pest attraction, and contamination.
- Plumbing cross-connections or backflow risks that can contaminate potable or food-contact water.
- Hand-washing/toilet facilities inadequate or poorly maintained, undermining personnel hygiene controls.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0.9× the rate of the average FDA-cited firm (7.0% vs 7.8%), across 738 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Your plant did not have adequate sanitary facilities and accommodations.
Your plant did not have adequate sanitary facilities and accommodations.
Your plant did not have adequate sanitary facilities and accommodations.
Your plant did not have adequate sanitary facilities and accommodations.
Your plant did not have adequate sanitary facilities and accommodations.
Your plant did not have adequate sanitary facilities and accommodations.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →